Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 12 studies | 33% ± 12% | |
endothelial cell of vascular tree | 9 studies | 39% ± 20% | |
vein endothelial cell | 7 studies | 40% ± 15% | |
endothelial cell of lymphatic vessel | 5 studies | 49% ± 11% | |
capillary endothelial cell | 4 studies | 24% ± 4% | |
endothelial cell of artery | 3 studies | 20% ± 2% |
Insufficient scRNA-seq data for expression of CCL14 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 6108.01 | 459 / 459 | 9% | 0.18 | 105 / 1118 |
bladder | 100% | 2494.52 | 21 / 21 | 5% | 0.09 | 25 / 504 |
liver | 89% | 1516.03 | 201 / 226 | 15% | 0.23 | 62 / 406 |
uterus | 99% | 4131.91 | 169 / 170 | 2% | 0.04 | 9 / 459 |
thymus | 99% | 2171.98 | 645 / 653 | 2% | 0.04 | 15 / 605 |
prostate | 91% | 1900.28 | 224 / 245 | 9% | 0.13 | 45 / 502 |
adipose | 100% | 5903.04 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 13402.35 | 241 / 241 | 0% | 0 | 0 / 0 |
intestine | 94% | 1313.18 | 907 / 966 | 5% | 0.07 | 24 / 527 |
adrenal gland | 92% | 1598.14 | 238 / 258 | 5% | 0.08 | 11 / 230 |
esophagus | 91% | 1794.96 | 1314 / 1445 | 6% | 0.08 | 11 / 183 |
kidney | 83% | 1404.26 | 74 / 89 | 13% | 0.25 | 113 / 901 |
lung | 80% | 1368.51 | 461 / 578 | 6% | 0.09 | 64 / 1155 |
blood vessel | 79% | 1681.85 | 1053 / 1335 | 0% | 0 | 0 / 0 |
skin | 65% | 950.83 | 1183 / 1809 | 1% | 0.02 | 5 / 472 |
stomach | 52% | 806.27 | 185 / 359 | 6% | 0.09 | 16 / 286 |
heart | 44% | 548.06 | 381 / 861 | 0% | 0 | 0 / 0 |
muscle | 40% | 339.63 | 318 / 803 | 0% | 0 | 0 / 0 |
ovary | 39% | 623.00 | 70 / 180 | 0% | 0.00 | 1 / 430 |
pancreas | 8% | 54.14 | 25 / 328 | 12% | 0.20 | 22 / 178 |
peripheral blood | 1% | 13.10 | 11 / 929 | 0% | 0 | 0 / 0 |
brain | 0% | 0.22 | 1 / 2642 | 0% | 0 | 0 / 705 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0070098 | Biological process | chemokine-mediated signaling pathway |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0006954 | Biological process | inflammatory response |
GO_0006874 | Biological process | intracellular calcium ion homeostasis |
GO_0043547 | Biological process | positive regulation of GTPase activity |
GO_0048245 | Biological process | eosinophil chemotaxis |
GO_0005615 | Cellular component | extracellular space |
GO_0048020 | Molecular function | CCR chemokine receptor binding |
GO_0008009 | Molecular function | chemokine activity |
Gene name | CCL14 |
Protein name | C-C motif chemokine 14 (C-C motif chemokine ligand 14) C-C motif chemokine C-C motif chemokine 14 (Chemokine CC-1/CC-3) (HCC-1/HCC-3) (HCC-1(1-74)) (NCC-2) (Small-inducible cytokine A14) [Cleaved into: HCC-1(3-74); HCC-1(4-74); HCC-1(9-74)] |
Synonyms | NCC2 SCYA14 |
Description | FUNCTION: Has weak activities on human monocytes and acts via receptors that also recognize MIP-1 alpha. It induces intracellular Ca(2+) changes and enzyme release, but no chemotaxis, at concentrations of 100-1,000 nM, and is inactive on T-lymphocytes, neutrophils, and eosinophil leukocytes. Enhances the proliferation of CD34 myeloid progenitor cells. The processed form HCC-1(9-74) is a chemotactic factor that attracts monocytes, eosinophils, and T-cells and is a ligand for CCR1, CCR3 and CCR5. . |
Accessions | ENST00000632700.1 [Q16627-1] ENST00000619040.4 [Q16627-2] Q16627 A0A087X089 ENST00000614009.1 ENST00000618060.2 ENST00000622526.1 [Q16627-2] ENST00000618404.5 [Q16627-1] A0A0B4J2G5 ENST00000620991.1 |